Publikationen von Rainer Landgraf
Alle Typen
Zeitschriftenartikel (250)
141.
Zeitschriftenartikel
55 (7), doi: 10.1016/j.biopsych.2003.10.021, S. 715 - 723 (2004)
Neurobiological correlates of high (HAB) versus low anxiety-related behavior (LAB): differential fos expression in HAB and LAB rats. Biological Psychiatry 142.
Zeitschriftenartikel
29, S. 1 - 14 (2004)
Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin. Neuropsychopharmacology 143.
Zeitschriftenartikel
3 (4-5), S. 239 - 244 (2003)
HAB/LAB rats: an animal model of extremes in trait anxiety and depression. Clinical Neuroscience Research 144.
Zeitschriftenartikel
36 (5), S. 239 - 239 (2003)
Modulation of CRH and AVP as a therapeutic strategy in anxiety disorders. Pharmacopsychiatry 145.
Zeitschriftenartikel
36 (5), S. 242 - 242 (2003)
Validation of a genetic mouse model for anxiety and comorbid depression. Pharmacopsychiatry 146.
Zeitschriftenartikel
36 (5), S. 250 - 251 (2003)
Molecular-genetic dissection of anxiety/depression: From HAB phenotype to functional SNP. Pharmacopsychiatry 147.
Zeitschriftenartikel
18 (2), S. 403 - 411 (2003)
Viral vector-mediated gene transfer of the vole V 1a vasopressin receptor in the rat septum: improved social discrimination and active social behaviour. European Journal of Neuroscience 148.
Zeitschriftenartikel
6 (2), S. 73 - 75 (2003)
Animal models of anxiety. Stress-the International Journal on the Biology of Stress 149.
Zeitschriftenartikel
6 (2), S. 111 - 119 (2003)
Born to be anxious: neuroendocrine and genetic correlates of trait anxiety in HAB rats. Stress 150.
Zeitschriftenartikel
57 (2), S. 107 - 108 (2003)
High trait anxiety in a genetic rat model: association with altered diazepam response and gene expression in the medial prefrontal/anterior cingulate cortex. Nordic Journal of Psychiatry 151.
Zeitschriftenartikel
28 (2), S. 235 - 243 (2003)
Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevate behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Neuropsychopharmacology 152.
Zeitschriftenartikel
28 (2), S. 379 - 383 (2003)
Steroid synthesis inhibition with ketoconazole and its effects upon the regulation of the hypothalamus-pituitary-adrenal system in healthy humans. Neuropsychopharmacology 153.
Zeitschriftenartikel
348 (2), S. 120 - 122 (2003)
Taurine regulates corticotropin secretion at the level of the supraoptic nucleus during stress in rats. Neuroscience Letters 154.
Zeitschriftenartikel
36 (1), S. 27 - 31 (2003)
The high-affinity non-peptide CRH1 receptor antagonist R121919 attenuates stress-induced alterations in plasma oxytocin, prolactin, and testosterone secretion in rats. Pharmacopsychiatry 155.
Zeitschriftenartikel
74, S. 274 - 278 (2003)
Neurobiologie und Genetik der Angst im Tiermodell. Nervenarzt 156.
Zeitschriftenartikel
28 (11), S. 1991 - 1999 (2003)
ABCBI (MDRI)- type P-Glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary-adrenocortical system: implications for affective disorder. Neuropsychopharmacology 157.
Zeitschriftenartikel
114 (7), S. 839 - 839 (2002)
Polymorphisms underlying innate anxiety. American Journal of Medical Genetics 158.
Zeitschriftenartikel
14, S. 1047 - 1055 (2001)
Taurine selectively modulates the secretory activity of vasopressin neurons in conscious rats. European Journal of Neuroscience 159.
Zeitschriftenartikel
13, S. 1254 - 1256 (2001)
Social isolation after a single defeat reduces striatal dopamine transporter binding in rats. European Journal of Neuroscience 160.
Zeitschriftenartikel
24, S. 337 - 349 (2001)
Neuroendocrine and behavioral effects of repetitive transcranial magnetic stimulation in a psychopathological animal model are suggestive of antidepressant-like effects. Neuropsychopharmacology